Back to today’s briefing

Story perspectives

New Study Unveils CRISPR Potential Against Hepatitis B

3/24/2025

29 7

Summary

Story summary

Chronic hepatitis B virus (HBV) infection poses a significant global health threat, largely due to the stubborn presence of covalently closed circular DNA (cccDNA). A recent study from Chongqing Medical University delves into the epigenetic regulation of cccDNA, unveiling promising therapeutic avenues such as targeting the HBV protein HBx and employing CRISPR/Cas9 technology to silence cccDNA, paving the way for a potential functional cure.

1 of 1

Story summary

Chronic hepatitis B virus (HBV) infection poses a significant global health threat, largely due to the stubborn presence of covalently closed circular DNA (cccDNA). A recent study from Chongqing Medical University delves into the epigenetic regulation of cccDNA, unveiling promising therapeutic avenues such as targeting the HBV protein HBx and employing CRISPR/Cas9 technology to silence cccDNA, paving the way for a potential functional cure.